Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2002
11/26/2002US6486340 Method for producing an α-aminonitrile from a tertiary anime and a cyanide through oxidation with oxygen by using a transition metal catalyst
11/26/2002US6486320 Preparation of camptothecin and of its derivatives
11/26/2002US6485529 Agent and method for coloring fibers
11/21/2002WO2002092602A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE
11/21/2002WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092570A1 Process for producing (3r,5s)-7-substituted-3,5-dihydroxyhept-6-enoic acid
11/21/2002WO2002092076A1 Substituted coumarins and quinolines as caspases activators
11/21/2002WO2002091830A1 Pyridinyl fused bicyclic amide as fungicides
11/21/2002WO2002081728A3 Quinoline inhibitors of hyak1 and hyak3 kinases
11/21/2002US20020173657 Method for the synthesis of quinoline derivatives
11/21/2002US20020173520 Quinoline derivatives
11/21/2002US20020173519 Quinoline derivatives
11/21/2002US20020173495 Selective androgen receptor modulators and methods of use thereof
11/21/2002US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof
11/21/2002US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002US20020173469 Protease inhibitors
11/21/2002CA2447150A1 Processes for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
11/21/2002CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/20/2002EP1258478A1 Process for producing quinolonecarboxylic acids and intermediates thereof
11/20/2002EP1258473A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
11/20/2002EP1258252A1 Integrin expression inhibitors
11/20/2002EP1257537A1 Therapeutic morpholino-substituted compounds
11/20/2002EP0882049B1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/19/2002US6482947 Substituted (hetero) aryl compounds, process for their preparation, agents containing them and their use as safeners
11/19/2002US6482859 Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives
11/19/2002US6482836 CRF antagonistic quino- and quinazolines
11/19/2002US6482835 Such as (r)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis
11/19/2002US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002CA2072162C Diastereomer salt of optically active quinolinemevalonic acid
11/14/2002WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002WO2002055014A3 Therapeutic chroman compounds
11/14/2002WO2002055013A3 Therapeutic chromone compounds
11/14/2002WO2002055012A3 Therapeutic heterocyclic compounds
11/14/2002WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002US20020169326 Fatty acid derivatives
11/14/2002US20020169197 Diaryl-enynes
11/14/2002US20020169186 Tetrahydroquinoline derivatives as glycine antagonists
11/14/2002US20020169185 Quinolinyl and benzothiazolyl modulators
11/14/2002US20020169180 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
11/14/2002CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/13/2002EP1256576A1 Fused imidazolium derivatives
11/13/2002EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002EP1255749A1 Tyrosine derivatives with anti-leukotriene activity
11/13/2002EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002CN1379774A Compounds
11/12/2002US6479660 Process for the preparation of anti-malarial drugs
11/12/2002US6479504 Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
11/12/2002US6479495 Simultaneously treating depression and memory dysfunction in mammals suffering from memory dysfunction and depression
11/12/2002US6479488 Good in vitro affinity for the strychnine insensitive glycine binding site associated with the nmda receptor complex but also good in vivo activity when administered systemically
11/12/2002US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/12/2002US6479436 Hetaroyl cyclohexanedione derivatives with herbicidal effect
11/12/2002CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002WO2002088087A1 Novel heterocyclic derivatives
11/07/2002WO2002088086A1 N-(3-quinolyl)amide derivative
11/07/2002WO2002088085A2 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors
11/07/2002WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002WO2002088069A2 Compounds useful as intermediates for 4-aminoquinoline derivatives
11/07/2002WO2002087581A1 Novel salt and crystalline forms of (2r)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy}quinoline
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002WO2001036365A3 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
11/07/2002US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002US20020165390 Preparation of quinoline-substituted carbonate and carbamate derivatives
11/07/2002US20020165253 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
11/07/2002US20020165252 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation
11/07/2002US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/07/2002US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002CA2445693A1 Compounds useful as intermediates for 4-aminoquinoline derivatives
11/07/2002CA2445623A1 Methods for preparing cetp inhibitors
11/07/2002CA2442608A1 Crystalline hydrochloride salt of (2r)-anti-5-(3-[-4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypoxy}quinoline
11/06/2002EP1254897A1 Tricyclic compounds
11/06/2002EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002EP1254101A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
11/06/2002EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002EP1253922A2 Statin-type bone growth stimulators
11/06/2002EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/05/2002US6476026 Compounds and compositions as protease inhibitors
11/05/2002CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
10/2002
10/31/2002WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002WO2002085857A2 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002WO2002085363A1 Remedial agent for glomerular disease
10/31/2002WO2002040474A3 Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002US20020161233 Which are useful as microsomal triglyceride transfer protein (MTP) inhibitors
10/31/2002US20020161008 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
10/31/2002CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions